Blinatumomab: Phase II started

Micromet began a single-arm, dose-escalation, international Phase II trial to evaluate daily IV

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE